Found: 21
Select item for more details and to access through your institution.
Pulmonary capillary hemangiomatosis incidentally detected in a lobectomy specimen for a metastatic colon cancer.
- Published in:
- Pathology International, 2006, v. 56, n. 6, p. 350, doi. 10.1111/j.1440-1827.2006.01971.x
- By:
- Publication type:
- Article
The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 2, p. 546, doi. 10.1245/s10434-016-5557-9
- By:
- Publication type:
- Article
Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 836, doi. 10.1007/s10147-019-01414-0
- By:
- Publication type:
- Article
A resected case of symptomatic acinar cell cystadenoma of the pancreas displacing the main pancreatic duct.
- Published in:
- Surgical Case Reports, 2016, v. 2, n. 1, p. 1, doi. 10.1186/s40792-016-0166-1
- By:
- Publication type:
- Article
Genomic characterization between HER2‐positive and negative gastric cancer patients in a prospective trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 15, p. 16649, doi. 10.1002/cam4.6269
- By:
- Publication type:
- Article
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
- Published in:
- Cancer Medicine, 2020, v. 9, n. 24, p. 9419, doi. 10.1002/cam4.3564
- By:
- Publication type:
- Article
Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 5, p. 1779, doi. 10.1002/cam4.2826
- By:
- Publication type:
- Article
A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 9, p. 4217, doi. 10.1002/cam4.1623
- By:
- Publication type:
- Article
Polyoxyethylene-modified Superoxide Dismutase Reduces Side Effects of Adriamycin and Mitomycin C.
- Published in:
- Cancer Science, 1992, v. 83, n. 8, p. 899, doi. 10.1111/j.1349-7006.1992.tb01997.x
- By:
- Publication type:
- Article
Aberrant Elevation of Tyrosine-specific Phosphorylation in Human Gastric Cancer Cells.
- Published in:
- Cancer Science, 1991, v. 82, n. 12, p. 1428, doi. 10.1111/j.1349-7006.1991.tb01816.x
- By:
- Publication type:
- Article
Phase I Evaluation of Continuous 5-Fluorouracil Infusion Followed by Weekly Paclitaxel in Patients with Advanced or Recurrent Gastric Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2005, v. 35, n. 6, p. 332, doi. 10.1093/jjco/hyi096
- By:
- Publication type:
- Article
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase II trial to evaluate the efficacy of panitumumab combined with fluorouracil-based chemotherapy for metastatic colorectal cancer: the PF trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 97, doi. 10.1007/s00280-015-2767-y
- By:
- Publication type:
- Article
TP53 Variant in the Blood of a Patient with Gastric Cancer Undergoing Tumor Profiling Tests Diagnosed as Clonal Hematopoiesis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 188, doi. 10.1007/s10120-021-01224-2
- By:
- Publication type:
- Article
Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 6, p. 753, doi. 10.1007/s11523-021-00845-y
- By:
- Publication type:
- Article
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial).
- Published in:
- Oncology Letters, 2017, v. 13, n. 2, p. 747, doi. 10.3892/ol.2016.5505
- By:
- Publication type:
- Article
Perioperative changes in carbonylhemoglobin and methemoglobin during abdominal surgery: Alteration in endogenous generation of carbon monoxide.
- Published in:
- Journal of Gastroenterology & Hepatology, 2002, v. 17, n. 5, p. 535, doi. 10.1046/j.1440-1746.2002.02685.x
- By:
- Publication type:
- Article